CANTON, Mass., Nov. 10 /PRNewswire/ -- Organogenesis, Inc., a leading regenerative medicine company, announced that Geoff MacKay, Chief Executive Officer, and Gary Gillheeney, Chief Operating Officer and Chief Financial Officer, received the prestigious Ernst & Young Entrepreneur Of The Year® 2009 Award in the biotechnology category in New England. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, growing businesses. MacKay and Gillheeney were selected by an independent panel of judges.
"This recognition is well deserved," said Dr. Susan Windham-Bannister, President & CEO of the Massachusetts Life Sciences Center. "Organogenesis is a growing company with a terrific future, having established itself as an industry leader in the expanding field of regenerative medicine. We at the Center are proud to have played a role in supporting Organogenesis in its expansion plans in Canton. Congratulations to Geoff, Gary and the entire Organogenesis team on receiving this prestigious honor."
The Ernst & Young Entrepreneur Of The Year awards celebrates its 23rd anniversary this year. The program honors entrepreneurs who have demonstrated excellence in such areas as innovation, financial performance and personal commitment to their businesses and communities.
"We are proud to recognize the achievements of Mr. MacKay and Mr. Gillheeney," said Kristin Keating, Ernst & Young LLP Entrepreneur Of The Year Program Co-Chair for New England. "Winners of the Entrepreneur Of The Year award build leading businesses and contribute significantly to the strength of our region's economy. Their success helps our area grow stronger."
As New England award winners, MacKay and Gillheeney are now eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year 2009 national program. Award winners in several national categor
|SOURCE Organogenesis, Inc.|
Copyright©2009 PR Newswire.
All rights reserved